Key result
Pediatric leukemia allogeneic stem cell transplant linked to ~16% lower FEV1 and reduced exercise capacity.
Why the study?
Allo-HSCT has improved survival in high-risk childhood leukemia but is associated with long-term sequelae such as impaired pulmonary function and reduced exercise capacity impacting quality of life.
Does allogeneic stem cell transplantation in survivors of pediatric leukemia impact regular physical activity, pulmonary function, and exercise capacity?
Observational (n=34)
No
Does allogeneic stem cell transplantation in survivors of pediatric leukemia impact regular physical activity, pulmonary function, and exercise capacity?
Absolute Event Rate: 90.5% vs 108%
p-value: p=0.002
Pediatric leukemia survivors who underwent allo-HSCT exhibit reduced exercise capacity and pulmonary diffusion capacity, particularly those who received total body irradiation, highlighting the need for targeted exercise counseling.
May warrant pulmonary monitoring and activity counseling in survivors; leaves open causality and intervention effects.
No takes yet. Share an insight, caveat, or question.
Ruf et al. (2021) conducted an observational in Pediatric leukemia survivors after allogeneic hematopoietic stem cell transplantation (n=34). Allogeneic hematopoietic stem cell transplantation vs. Healthy controls was evaluated on FEV1 (% predicted) (p=0.002). Pediatric leukemia survivors after allogeneic stem cell transplantation had significantly reduced pulmonary function (FEV1 90.5% vs 108.0% predicted) and exercise capacity compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: